Corporate Support
Sitemap
Singapore

ShareInvestor.com

Mobile Edition
Mode - Streaming
Switch to Static Mode?

Price Highlight

Index Highlight

Chart
STI
2,595.3
32.1 (1.25%)

 

  • STI Straits Times Index
    2,595.3
    32.1 (1.25%)
     
  • KLCI FTSE Bursa Malaysia KLCI
    1,569.7
    13.1 (0.84%)
    Index delayed 15 minutes
  • HSI Hang Seng Index
    25,215.6
    -28.4 (-0.11%)
    Index delayed 15 minutes
  • SSE SSE Composite Index
    3,322.8
    3.6 (0.11%)
    Index delayed 15 minutes
  • N225 Nikkei 225
    23,272.3
    428.4 (1.88%)
    Index delayed 20 minutes
  • JCI Jakarta Composite Index
    5,229.8
    -3.7 (-0.07%)
    Index delayed 10 minutes

SGX Market

Bursa Market

HKEx Market

SET Market

IDX Market

ASX Market

NYSE Market

NASDAQ Market

NYSE American Market

  • Volume: 668.7M
  • Value: 632.7M
  • Rise: 210
  • Fall: 70
  • Unch: 528

Intraday Market Ticker Help

Intraday Market Ticker
Time Name Type Price Vol
  • Top Active

  • Top Gainer

  • Top Loser

Top Counters
Name Last Change
Jiutian Chemical0.026+0.008
Medtecs Intl1.570+0.160
QT Vascular0.008+0.001
ThaiBev0.610+0.010
Sembcorp Marine0.245-0.105
UMS1.170+0.090
Rex Intl0.184+0.002
Genting Sing0.725+0.020
IPS Securex0.117+0.005
YZJ Shipbldg SGD0.960+0.010

World Indices

World Indices
Name Last Change
Nasdaq 9,757.2 -259.8
HSI 24,265.5 -284.5
HSCEI 9,743.2 -110.0
Jakarta 4,863.1 -41.0
Nikkei 225 22,047.8 -464.2
SSE Comp 2,960.5 -10.1
Shanghai A 3,103.1 -10.6
Shanghai B 211.8 -1.7
KOSPI 2,097.3 -37.3

Asian Indices delayed. US Indices updated twice daily at 7:30am and 7:30pm.

Fundamental - Factsheet

Help
  • Factsheet

  • Print

CYNATA THERAPEUTICS LTD CYNATA THERAPEUTICS
Updated on 12 Aug 2020 (End of trading day)
Last (AUD): 0.625 Change: -0.005 High: 0.630 Remarks: -
Change (%): -0.79 Low: 0.600
Open 0.630 Yesterday's Close 0.63
Buy Price - Sell Price -
Buy Volume (share) - Sell Volume (share) -
Cumulative Volume (share) 443,355 Cumulative Value
Click to show Stock Prices chart

Key Statistics

EPS (AUD) a -0.07233 Trailing EPS (AUD) e -0.06865 NAV (AUD) b 0.0831
PE a - Trailing PE f - Price / NAV b 7.5211
Dividend (AUD) d - Cash In Hand (AUD) g 0.0505 Issued & Paid-up Shares c 117,124,000
Dividend Yield (%) d - Price / Cash In Hand g 12.376 Treasury Shares h -
Beta - 75 Daysi 1.941 R-Squared - 75 Days(%)i 17.44 Market Cap (M) 73.203
Beta - 500 Daysi 0.762 R-Squared - 500 Days (%)i 2.09 Enterprise Value (M) 67.284
Piotroski F Score 1 Exchange Code CYP Par Value ( AUD ) n.a.
52 Weeks Volatility (%) 57.58 Free Float (%) 79.0
Sector & Industry Health Technology - Biotechnology
Notes:
  1. Based on latest Full Year results announcement, adjusted for the current number of shares.
  2. Based on latest results announcement (Full Year, Half Year or Interim), adjusted for carrying value of "Other Share Capital", illustrative financial effects of corporate actions (if applicable) and the current number of shares.
  3. Rounded to the nearest thousand. Updated on 10 Jun 2020.Please click here for more information.
  4. Dividend is based on latest Full Year results announcement, adjusted for current number of shares and excludes special dividend.
  5. Summation of the earnings from the latest 4 Quarter (or 2 Half Year) results announcement, adjusted for the current number of shares.
  6. Based on Trailing EPS.
  7. Based on reported cash and cash equivalents at end and extracted from the latest results announcement (Full Year, Half Year or Interim), adjusted for the current number of shares.
  8. Rounded to the nearest thousand. Updated on 29 Jul 2015.
  9. Beta and R-Squared are calculated in relation to the market index using the historical daily closing values of the stock and index as data points.

Peer Comparison

Type Name Market Market Cap (M)a PE b Trailing PE c Price / NAV d Dividend Yield (%)d
Reference CYNATA THERAPEUTICS LTD ASX 73.203 - - 7.5211 -
Industry Biotechnology ASX 3,595.160 56.407 51.108 13.5278 0.905
Local Peer CSL ASX 127,919.225 47.679 44.159 14.7911 0.941
Local Peer MESOBLAST LTD ASX 1,783.477 - - 2.2378 -
Local Peer POLYNOVO LIMITED ASX 1,388.285 - - 56.6038 -
Local Peer TELIX PHARMACEUTIC ASX 341.555 - - 4.8732 -
Local Peer IMUGENE LIMITED ASX 245.618 - - 3.7671 -
Local Peer NEXT SCIENCE LTD ASX 233.288 - - 8.4707 -
Local Peer NEUREN PHARMACEUTICALS LTD ASX 150.538 - - 10.8751 -
Local Peer ANTEOTECH LIMITED ASX 92.019 - - 28.9474 -
Local Peer MEMPHASYS LTD ASX 94.247 - - 9.4697 -
Local Peer IMMUTEP LTD ASX 92.650 - - 3.3043 -
Local Peer GENETIC TECHNOLOGIES ASX 74.356 - - 30.0000 -
Local Peer INVEX THERAPEUTICS LTD NPV ASX 74.402 - - - -
Other Local Peers KAZIA THERAPEUTICS LIMITED (ASX), BIOTRON (ASX), ALTERITY THERAPEUTICS LIMITED (ASX), BIONOMICS LTD (ASX), REGENEUS LTD (ASX), CONSTELLATION TECHNOLOGIES LTD (ASX), ACTINOGEN MEDICAL LTD (ASX), PRESCIENT THERAPEUTICS LIMITED (ASX), RHINOMED LIMITED (ASX), PATRYS LIMITED (ASX), ADALTA LTD (ASX), CONTANGO ASSET MANAGEMENT LIMITED (ASX), HOLISTA COLLTECH LIMITED (ASX), NEUROSCIENTIFIC BIOPHARMA LTD (ASX), AMPLIA THERAPEUTICS LTD (ASX), AVECHO BIOTECHNOLOGY LTD (ASX), AUSTRALIAN PRIMARY HEMP LTD (ASX), LIVING CELL TECHNOLOGIES (ASX), CRYOSITE (ASX), ANATARA LIFESCIENCES LTD (ASX), LEAF RESOURCES LTD (ASX), FACTOR THERAPEUTICS LIMITED (ASX), NANOLLOSE LTD (ASX)
Global Peer AMGEN INC NASDAQ 141,573.954 18.053 19.396 13.2821 2.423
Global Peer GILEAD SCIENCES INC NASDAQ 86,306.085 16.024 - 4.7876 3.697
Global Peer AMGEN-T HKEx 585,694.000 9.532 10.295 7.0897 4.589
Global Peer VERTEX PHARMACEUTICAL NASDAQ 70,547.487 59.948 33.904 9.3823 -
Global Peer REGENERON PHARMACEUTICALS INC NASDAQ 65,149.123 30.792 21.836 7.1929 -
Global Peer ILLUMINA INC NASDAQ 50,244.440 50.144 72.503 11.0113 -
Global Peer BIOGEN INC NASDAQ 46,420.538 7.883 7.832 4.1049 -
Global Peer MODERNA INC NASDAQ 27,431.688 - - 9.3087 -
Global Peer WUXI BIO HKEx 222,417.137 193.479 193.479 15.5530 -
Global Peer SEATTLE GENETICS INC NASDAQ 27,628.984 - - 15.2303 -
Other Global Peers ALEXION PHARMACEUTICAL INC (NASDAQ), SINO BIOPHARM (HKEx), BIOMARIN PHARMACEUTICAL (NASDAQ), INCYTE CORPORATION (NASDAQ), BEIGENE LTD SPON ADS EACH REPR 13 ORD SHS (NASDAQ), BEIGENE (HKEx), BIONTECH SE SPON ADS EACH REP 1 ORD SHS (NASDAQ), ALNYLAM PHARMACEUTICALS INC (NASDAQ), EXACT SCIENCES CORP (NASDAQ), SAREPTA THERAPEUTICS INC (NASDAQ), GALAPAGOS NV SPON ADR REPR 1 ORD SHS (NASDAQ), NEUROCRINE BIOSCIENCES INC (NASDAQ), BIO-TECHNE CORP (NASDAQ), 10X GENOMICS INC (NASDAQ), IMMUNOMEDICS INC (NASDAQ), NOVAVAX INC (NASDAQ), IONIS PHARMACEUTICALS INC (NASDAQ), ASCENDIS PHARMA A/S SPON ADR EACH REP 1 ORD SHS (NASDAQ), EXELIXIS INC (NASDAQ), VIR BIOTECHNOLOGY INC (NASDAQ), EMERGENT BIOSOLUTIONS INC (NYSE), ACADIA PHARMACEUTICALS INC (NASDAQ), CRISPR THERAPEUTICS AG (NASDAQ), ZAI LAB LIMITED ADS EACH REP 1 ORD SHS (NASDAQ), MIRATI THERAPEUTICS INC (NASDAQ), ACCELERON PHARMA (NASDAQ), ULTRAGENYX PHARMACEUTICAL INC (NASDAQ), ALLOGENE THERAPEUTICS INC (NASDAQ), Lonza (SGX), MORPHOSYS SPON ADS EACH REP 0.25 ORD SHS (NASDAQ), ARROWHEAD PHARMACEUTICALS INC (NASDAQ), BLUEBIRD BIO INC (NASDAQ), IOVANCE BIOTHERAPEUTICS INC (NASDAQ), BLUEPRINT MEDICINES CORP (NASDAQ), CHINA BIOLOGIC PRODUCTS HLDGS INC (NASDAQ), FIBROGEN INC (NASDAQ), HALOZYME THERAPEUTICS INC (NASDAQ), AMICUS THERAPEUTICS INC (NASDAQ), GENSCRIPT BIO (HKEx), GLOBAL BLOOD THERAPEUTICS INC (NASDAQ), CHEMOCENTRYX INC (NASDAQ), ARENA PHARMACEUTICALS INC (NASDAQ), RELAY THERAPEUTICS INC (NASDAQ), DENALI THERAPEUTICS INC (NASDAQ), BRIDGEBIO PHARMA INC (NASDAQ), SORRENTO THERAPEUTICS INC (NASDAQ), MOMENTA PHARMACEUTICALS INC (NASDAQ), PTC THERAPEUTICS INC (NASDAQ), FATE THERAPEUTICS (NASDAQ), 3SBIO (HKEx), INSMED INC (NASDAQ), ALKERMES PLC (NASDAQ), AGIOS PHARMACEUTICALS INC (NASDAQ), BENITEC BIOPHARMA INC (NASDAQ), ALLOVIR INC (NASDAQ), DECIPHERA PHARMACEUTICALS INC (NASDAQ), TWIST BIOSCIENCE CORPORATION (NASDAQ), HAOHAI BIOTEC (HKEx), TG THERAPEUTICS INC (NASDAQ), VIVA BIOTECH (HKEx), KODIAK SCIENCES INC (NASDAQ), EDITAS MEDICINE INC (NASDAQ), VIELA BIO INC (NASDAQ), VAXCYTE INC (NASDAQ), VERACYTE INC (NASDAQ), ALPHAMAB-B (HKEx), XENCOR INC (NASDAQ), UNIQURE N.V. (NASDAQ), LIGAND PHARMACEUTICAL INC (NASDAQ), SANGAMO THERAPEUTICS INC (NASDAQ), EIDOS THERAPEUTICS INC (NASDAQ), AURINIA PHARMACEUTICALS INC (NASDAQ), SERES THERAPEUTICS (NASDAQ), ROCKET PHARMACEUTICALS INC (NASDAQ), MYOVANT SCIENCES LTD (NYSE), ARCUS BIOSCIENCES INC (NYSE), DICERNA PHARMACEUTICALS INC. (NASDAQ), AKEBIA THERAPEUTICS INC (NASDAQ), MACROGENICS INC (NASDAQ), CYTOKINETICS INC (NASDAQ), LUMINEX CORP(DEL) (NASDAQ), HERON THERAPEUTICS INC (NASDAQ), ZENTALIS PHARMACEUTICALS INC (NASDAQ), COMPUGEN (NASDAQ), NANOSTRING TECHNOLOGIES INC (NASDAQ), COHERUS BIOSCIENCES INC (NASDAQ), MESOBLAST LTD SPON ADR EACH REP 5 SHS (NASDAQ), CORTEXYME INC (NASDAQ), EPIZYME INC (NASDAQ), NGM BIOPHARMACEUTICALS INC (NASDAQ), MERSANA THERAPEUTICS INC (NASDAQ), INTRA-CELLUAR THERAPIES INC (NASDAQ), ADAPTIMMUNE THERAPEUTICS PLC SPON ADS EACH REP 6 ORD SHS (NASDAQ), ADVERUM BIOTECHNOLOGIES INC (NASDAQ), REGENXBIO INC (NASDAQ), BEAM THERAPEUTICS INC (NASDAQ), VAXART INC (NASDAQ), BLACK DIAMOND THERAPEUTICS INC (NASDAQ), KURA ONCOLOGY INC (NASDAQ), INTELLIA THERAPEUTICS INC (NASDAQ), ALECTOR INC (NASDAQ), AVIDITY BIOSCIENCES INC (NASDAQ), ARVINAS INC (NASDAQ), KARYOPHARM THERAPEUTICS INC (NASDAQ), TRANSLATE BIO INC (NASDAQ), BIOXCEL THERAPEUTICS INC (NASDAQ), NANTKWEST INC (NASDAQ), ITEOS THERAPEUTICS INC (NASDAQ), ASCENTAGE-B (HKEx), FRONTAGE (HKEx), REPLIMUNE GROUP INC (NASDAQ), ENANTA PHARMACEUTICALS INC (NASDAQ), STOKE THERAPEUTICS INC (NASDAQ), RETROPHIN INC (NASDAQ), MYRIAD GENETICS INC (NASDAQ), ESPERION THERAPEUTICS INC (NASDAQ), ATARA BIOTHERAPEUTICS INC (NASDAQ), AIMMUNE THERAPEUTICS INC (NASDAQ), PLIANT THERAPEUTICS INC (NASDAQ), OMEROS CORP (NASDAQ), MORPHIC HOLDING INC (NASDAQ), VBI VACCINES INC CDA (NASDAQ), CARA THERAPEUTICS INC (NASDAQ), RHYTHM PHARMACEUTICALS INC (NASDAQ), AUTOLUS THERAPEUTICS PLC SPON ADS EA REP 1 ORD SHS (NASDAQ), PRECIGEN INC (NASDAQ), NKARTA INC (NASDAQ), FREQUENCY THERAPEUTICS INC (NASDAQ), DYNAVAX TECHNOLOGIES CORP (NASDAQ), MERIDIAN BIOSCIENCE INC COM (NASDAQ), POSEIDA THERAPETUICS INC (NASDAQ), APPLIED MOLECULAR TRANSPORT INC (NASDAQ), CELLECTIS ADS EACH REPR 1 ORD SPON (NASDAQ), ZIOPHARM ONCOLOGY INC (NASDAQ), PASSAGE BIO INC (NASDAQ), KINTOR PHARMA-B (HKEx), KADMON HLDGS INC (NYSE), BIOCRYST PHARMACEUTICALS INC (NASDAQ), TRILLIUM THERAPEUTICS INC (NASDAQ), PACIFIC BIOSCIENCES CALIFORNIA INC (NASDAQ), PERSONALIS INC (NASDAQ), IMMUNOGEN INC (NASDAQ), IMMATICS N V (NASDAQ), AKOUOS INC (NASDAQ), VANDA PHARMACE INC (NASDAQ), AGENUS INC (NASDAQ), CO DIAGNOSTICS INC (NASDAQ), PROTAGONIST THERAPEUTICS INC (NASDAQ), AVROBIO INC (NASDAQ), UNITY BIOTECHNOLOGY INC (NASDAQ), MOLECULAR TEMPLATES INC (NASDAQ), FLEXION THERAPEUTICS INC (NASDAQ), RADIUS HEALTH INC (NASDAQ), CUE BIOPHARMA INC (NASDAQ), CORBUS PHARMACEUTICALS HOLDINGS IN (NASDAQ), SYNDAX PHARMACEUTICALS INC (NASDAQ), FREELINE THERAPEUTICS HLDGS PLC SPON ADS EACH REP 1 ORD SHS (NASDAQ), VIKING THERAPEUTICS INC (NASDAQ), SYROS PHARMACEUTICALS INC (NASDAQ), RAPT THERAPEUTICS INC (NASDAQ), PANDION THERAPEUTICS INC (NASDAQ), UROGEN PHARMA LTD (NASDAQ), DPHARMA (Bursa), SPECTRUM PHARMACEUTICALS INC (NASDAQ), MEIRAGTX HOLDINGS PLC (NASDAQ), INNATE PHARMA SPON ADS EACH REP 1 ORD SHS (NASDAQ), HOMOLOGY MEDICINES INC (NASDAQ), PROTHENA CORP PLC (NASDAQ), ARDELYX INC (NASDAQ), GERON CORP (NASDAQ), NEOLEUKIN THERAPEUTICS INC (NASDAQ), ANAPTYSBIO INC (NASDAQ), XBIOTECH INC (NASDAQ), PREVAIL THERAPEUTICS INC (NASDAQ), SINOVAC BIOTECH LTD (NASDAQ), INVENTIVA SA SPON ADS EACH REP 1 ORD SHS (NASDAQ), BIOFRONTERA AG SPON ADS EACH REP TWO ORD SHS (NASDAQ), ATHERSYS INC (NASDAQ), SINOMAB BIO-B (HKEx), TIZIANA LIFE SCIENCES PLC SPON ADS EACH REPR 10 ORD SHS (NASDAQ), AVID BIOSERVICES INC (NASDAQ), LEE'S PHARM (HKEx), ASCLETIS-B (HKEx), CLOVIS ONCOLOGY INC (NASDAQ), RIGEL PHARMACEUTICALS INC (NASDAQ), APTOSE BIOSCIENCES INC (NASDAQ), LIMINAL BIOSCIENCES INC (NASDAQ), VOYAGER THERAPEUTICS INC (NASDAQ), RUBIUS THERAPEUTICS INC (NASDAQ), ASPIRA WOMENS HEALTH INC (NASDAQ), BRAINSTROM CELL THERAPEUTICS (NASDAQ), PUMA BIOTECHNOLOGY INC (NASDAQ), CYMABAY THERAPEUTICS INC (NASDAQ), IVERIC BIO INC (NASDAQ), XENON PHARMACEUTICALS INC (NASDAQ), SCHOLAR ROCK HOLDING CORPORATION (NASDAQ), NANOVIRICIDES INC (NYSE American), KAMADA (NASDAQ), MERUS B V (NASDAQ), MANNKIND CORPORATION (NASDAQ), ESSEX BIO-TECH (HKEx), PDL BIOPHARMA INC (NASDAQ), PRECISION BIOSCIENCES INC (NASDAQ), HARPOON THERAPEUTICS INC (NASDAQ), MAGENTA THERAPEUTICS INC (NASDAQ), WAVE LIFE SCIENCES LTD (NASDAQ), EIGER BIOPHARMACEUTICALS INC (NASDAQ), NEPTUNE WELLNESS SOLUTIONS INC (NASDAQ), CYTOMX THERAPEUTICS INC (NASDAQ), IMV INC (NASDAQ), PROQR THERAPEUTICS N V (NASDAQ), PFENEX INC (NYSE American), CAN FITE BIOPHARMA LTD SPON ADS EA REP 30 ORD SHS(POST REV SPL (NYSE American), CONCERT PHARMACEUTICALS INC (NASDAQ), CABALETTA BIO INC (NASDAQ), TREVENA INC (NASDAQ), CALITHERA BIOSCIENCES INC (NASDAQ), AEGLEA BIOTHERAPEUTICS INC (NASDAQ), BICYCLE THERAPEUTICS PLC SPON ADS EACH REP 1 ORD SHS (NASDAQ), SELECTA BIOSCIENCES INC (NASDAQ), ARBUTUS BIOPHARMA CORP (NASDAQ), CELLULAR BIOMEDICINE GROUP INC (NASDAQ), HEAT BIOLOGICS INC (NASDAQ), AFFIMED N V (NASDAQ), MEDICINOVA INC (NASDAQ), NEXTCURE INC (NASDAQ), IBIO INC (NYSE American), ALDEYRA THERAPEUTICS (NASDAQ), DBV TECHNOLOGIES SPON ADR EACH REPR 0.5 ORD (NASDAQ), CHIASMA INC (NASDAQ), ADMA BIOLOGICS INC (NASDAQ), FORTRESS BIOTECH INC (NASDAQ), DYADIC INTERNATIONAL INC (NASDAQ), CASI PHARMACEUTICALS INC (NASDAQ), EVOFEM BIOSCIENCES INC (NASDAQ), SUMMIT THERAPEUTICS PLC ADS EACH REPR 5 ORD (NASDAQ), ANAVEX LIFE SCIENCES CORPORATION (NASDAQ), VERASTEM INC (NASDAQ), T2 BIOSYSTEMS INC (NASDAQ), PLURISTEM THERAPEUTICS INC (NASDAQ), STRONGBRIDGE BIOPHARMA PLC (NASDAQ), TAIWAN LIPOSOME COMPANY LTD SPON ADS EACH REP 2 ORD SHS (NASDAQ), KEZAR LIFE SCIENCES INC (NASDAQ), LEXICON PHARMACEUTICALS INC (NASDAQ), ADURO BIOTECH INC (NASDAQ), AXCELLA HEALTH INC (NASDAQ), GENFIT SPON ADS EACH REP 1 ORD SHS (NASDAQ), PARATEK PHARMACEUTICALS INC (NASDAQ), ONCONOVA THERAPEUTICS INC (NASDAQ), ALPINE IMMUNE SCIENCES INC (NASDAQ), NUCANA PLC SPON ADR EACH REP 1 ORD SHS (NASDAQ), MEREO BIOPHARMA GROUP PLC SPON ADS EACH REP 5 ORD SHS (NASDAQ), CHIMERIX INC (NASDAQ), XOMA CORP (NASDAQ), GLYCOMIMETICS INC (NASDAQ), EQUILLIUM INC (NASDAQ), FIVE PRIME THERAPEUTICS (NASDAQ), VTV THERAPEUTICS INC (NASDAQ), FENNEC PHARMACEUTICALS INC (NASDAQ), SURFACE ONCOLOGY INC (NASDAQ), CIDARA THERAPEUTICS INC (NASDAQ), PIERIS PHARMACEUTICALS INC (NASDAQ), OUTLOOK THERAPEUTICS INC (NASDAQ), JOUNCE THERAPEUTICS INC (NASDAQ), OTONOMY INC (NASDAQ), BELLUS HEALTH INC (NASDAQ), WINDTREE THERAPEUTICS INC (NASDAQ), GALECTIN THERAPEUTICS INC (NASDAQ), NEUROINSIGHTS NEUROTECH (NASDAQ), APPLIED GENETIC TECHNOLOGIES CORP (NASDAQ), HARVARD BIOSCIENCE INC (NASDAQ), CONTRAFECT CORP (NASDAQ), CELYAD ADS EACH REPR 1 ORD (NASDAQ), X4 PHARMACEUTICALS INC (NASDAQ), AVALON GLOBOCARE CORP (NASDAQ), LINEAGE CELL THERAPEUTICS INC (NYSE American), INMUNE BIO INC (NASDAQ), CAPRICOR THERAPEUTICS INC (NASDAQ), ERYTECH PHARMA SPON ADR EACH REPR 1 ORD (NASDAQ), CATABASIS PHARMACEUTICALS INC (NASDAQ), SIERRA ONCOLOGY INC (NASDAQ), ELOXX PHARMACEUTICALS INC (NASDAQ), LUMOS PHARMA INC (NASDAQ), ORGENESIS INC (NASDAQ), INFLARX N V (NASDAQ), ENZO BIOCHEM INC (NYSE), SESEN BIO INC (NASDAQ), SOLID BIOSCIENCES INC (NASDAQ), CATALYST BIOSCIENCES INC (NASDAQ), CHAMPIONS ONCOLOGY INC (NASDAQ), BIONANO GENOMICS INC (NASDAQ), CEL-SCI CORP (NYSE American), AVEO PHARMACEUTICALS INC (NASDAQ), NEUROBO PHARMACEUTICALS INC (NASDAQ), SAVARA INC (NASDAQ), LEAP THERAPEUTICS INC (NASDAQ), NABRIVA THERAPEUTICS PLC (NASDAQ), EDAP TMS S.A. SPON ADR EACH REPR 1 ORD SHARE (NASDAQ), UNI-BIO GROUP (HKEx), LA JOLLA PHARMACEUTICAL CO (NASDAQ), ORGANOVO HLDGS INC (NASDAQ), VACCINEX INC (NASDAQ), STEALTH BIOTHERAPEUTICS CORP SPON ADS EACH REP 12 ORD SHS (NASDAQ), UNUM THERAPEUTICS INC (NASDAQ), ARAVIVE INC (NASDAQ), AIM IMMUNOTECH INC (NYSE American), RESTORBIO INC (NASDAQ), PALATIN TECHNOLOGIES INC (NYSE American), GENOCEA BIOSCIENCES INC (NASDAQ), SYNLOGIC INC (NASDAQ), OCUGEN INC (NASDAQ), AQUABOUNTY TECHNOLOGIES INC (NASDAQ), ENTASIS THERAPEUTICS HLDGS INC (NASDAQ), MONOPAR THERAPEUTICS INC (NASDAQ), MATINAS BIOPHARMA HOLDINGS INC (NYSE American), ONCOLYTICS BIOTECH INC (NASDAQ), IDERA PHARMACEUTICALS INC (NASDAQ), DIAMEDICA THERAPEUTICS INC (NASDAQ), SYNTHETIC BIOLOGICS INC (NYSE American), RECRO PHARMA INC (NASDAQ), AXOVANT GENE THERAPIES LTD (NASDAQ), 22ND CENTURY GROUP INC (NYSE American), COHBAR INC (NASDAQ), DIFFUSION PHARMACEUTICALS INC (NASDAQ), 9 METERS BIOPHARMA INC (NASDAQ), CURIS INC (NASDAQ), INFINITY PHARMACEUTICALS INC (NASDAQ), PROTEOSTASIS THERAPEUTICS INC (NASDAQ), IMMUTEP LTD SPON ADS EACH REP 10 ORD SHS (NASDAQ), MIRAGEN THERAPEUTICS INC (NASDAQ), ANIXA BIOSCIENCES INC (NASDAQ), VISTAGEN THERAPEUTICS INC (NASDAQ), ASLAN PHARMACEUTICALS LIMITED ADS EACH REP 5 ORD SHS (NASDAQ), ARMATA PHARMACEUTICALS INC (NYSE American), VASCULAR BIOGENICS LTD (NASDAQ), SOLIGENIX INC (NASDAQ), ANPAC BIO MEDICAL SCIENCE CO LTD SPON ADS EACH REPR 1 ORD SHS CLASS A (NASDAQ), KAZIA THERAPEUTICS LIMITED SPON ADR EACH REP 10 ORD SHS (NASDAQ), SUNESIS PHARMACEUTICALS INC (NASDAQ), SEELOS THERAPEUTICS INC (NASDAQ), ALTERITY THERAPEUTICS LIMITED SPON ADS EA REPR 60 ORD SHS (NASDAQ), PRECIPIO INC (NASDAQ), MICROBOT MEDICAL INC (NASDAQ), CT ENTERPRISE (HKEx), MERRIMACK PHARMACEUTICALS INC (NASDAQ), ORAGENICS INC (NYSE American), PULMATRIX INCORPORATED (NASDAQ), FORWARD PHARMA AS SPON ADS EACH REP 14 ORD SHS (NASDAQ), HTG MOLECULAR DIAGNOSTICS INC (NASDAQ), ARCA BIOPHARMA INC (NASDAQ), OPIANT PHARMACEUTICALS INC (NASDAQ), AIKIDO PHARMA INC (NASDAQ), CELLECTAR BIOSCIENCES INC (NASDAQ), BELLICUM PHARMACEUTICALS (NASDAQ), ATYR PHARMA INC (NASDAQ), ACHIEVE LIFE SCIENCE INC (NASDAQ), GENETIC TECHNOLOGIES SPON ADS EA REP 600 ORD SHS(R/S) (NASDAQ), CLEVELAND BIOLABS INC (NASDAQ), ADVAXIS INC (NASDAQ), ACORDA THERAPEUTICS INC (NASDAQ), AETERNA ZENTARIS INC (NASDAQ), BIOCARDIA INC (NASDAQ), ALIMERA SCIENCES INC (NASDAQ), BIOSINO BIO-TEC (HKEx), EVOGENE LTD (NASDAQ), AZURRX BIOPHARMA INC (NASDAQ), ADITX THERAPEUTICS INC (NASDAQ), SONNET BIOTHERAPEUTICS HLDGS INC (NASDAQ), APTEVO THERAPEUTICS INC (NASDAQ), Suntar Eco-City (SGX), CYCLACEL PHARMACEUTICALS INC (NASDAQ), SELLAS LIFE SCIENCES GROUP INC (NASDAQ), REGENT PACIFIC (HKEx), ITERUM THERAPEUTICS PLC (NASDAQ), INDIA GLOBALIZATION CAPITAL INC (NYSE American), BIO-PATH HOLDINGS INC (NASDAQ), PHIO PHARMACEUTICALS CORP (NASDAQ), ENDRA LIFE SCIENCES INC (NASDAQ), NOVABAY PHARMACEUTICALS INC (NYSE American), TRACON PHARMACEUTICALS INC (NASDAQ), SENECA BIOPHARMA INC (NASDAQ), PLUS THERAPEUTICS INC (NASDAQ), CELLECT BIOTECHNOLOGY LTD SPON ADS EACH REP 100 ORD SHS(POST SPLT) (NASDAQ), REXAHN PHARMACEUTICALS INC (NASDAQ), MIDATECH PHARMA PLC SPON ADS EACH REP 5 ORD SHS(R/S) (NASDAQ), XTL BIOPHARMACEUTICALS LTD SPON ADS EACH REP 100 ORD SHS(POST SPLT) (NASDAQ), XENETIC BIOSCIENCES INC (NASDAQ), ANCHIANO THERAPEUTICS LTD SPON ADS EACH REP 5 ORD SHS (NASDAQ), INVIVO THERAPEUTICS HOLDING CORP (NASDAQ), SENESTECH INC (NASDAQ), HAO WEN H-NEW (HKEx), AURIS MEDICAL HOLDING LTD (NASDAQ), HAO WEN H-OLD (HKEx)
Notes:
  1. For companies, Market Cap is based on the trading currency of the company. Industry/Index Market Cap is the average market cap for that industry/index.
  2. Industry/Index PE is calculated using (Total Market Cap/Total Earnings) of all companies in the industry/index.
  3. Industry/Index Price/NAV is calculated using (Total Market Cap/Total Shareholders' Equity) of all companies in the industry/index.
  4. Industry/Index Dividend Yield is calculated using (Total Gross Dividend/Total Market Cap) of all companies in the industry/index.
  5. For Industry/Index calculation, data for foreign currency denominated companies will be converted to the main market currency using the latest exchange rate.
  6. Industry/Index/Peers data is updated daily.
  7. Peers are sorted by market capitalisation and only details for the top 10 will be shown.

Total Shareholder Return

PeriodDividend ReceivedCapital AppreciationTotal Shareholder Return
Short Term Return 5 Days --0.005
-0.79 %
10 Days ---
20 Days -+0.020
+3.31 %
Medium Term Return 3 Months --0.055
-8.09 %
6 Months --0.465
-42.66 %
1 Year --1.075
-63.24 %
Long Term Return 2 Years --0.550
-46.81 %
3 Years -+0.045
+7.76 %
5 Years -+0.030
+5.04 %
Annualised Return Annualised --
+0.99 %
Notes:
  1. Total Shareholder Return (TSR) combines share price appreciation and dividends paid to show the total return to the shareholder expressed as a percentage.
  2. Script dividends are ignored in this calculation.

Price Movements

1 Year Range 0.580 - 1.795 Change From 1 Year Low +0.045 % Change From 1 Year Low (%) +7.76
Change From 1 Year High -1.170 % Change From 1 Year High (%) -65.18
2 Years Range 0.580 - 1.870 Change From 2 Years Low +0.045 % Change From 2 Years Low (%) +7.76
Change From 2 Years High -1.245 % Change From 2 Years High (%) -66.58
5 Years Range 0.225 - 1.870 Change From 5 Years Low +0.400 % Change From 5 Years Low (%) +177.78
Change From 5 Years High -1.245 % Change From 5 Years High (%) -66.58
Notes:
  1. Price movements are based on adjusted historical data.

Company Background

Cynata Therapeutics Ltd. engages in the development and commercialization of therapeutic products. It focuses on therapeutic stem cell platform technology. The company was founded on March 12, 2003 and is headquartered in Carlton, Australia.

Historical Price Data

Date Open High Low Close Volume VWAP
12 Aug 2020 0.630 0.630 0.600 0.625 443,355 -
11 Aug 2020 0.660 0.670 0.615 0.630 616,450 -
10 Aug 2020 0.675 0.690 0.655 0.675 293,605 -
07 Aug 2020 0.645 0.675 0.645 0.670 235,596 -
06 Aug 2020 0.630 0.645 0.625 0.645 161,682 -
05 Aug 2020 0.630 0.635 0.630 0.630 87,613 -
04 Aug 2020 0.630 0.635 0.625 0.630 116,250 -
03 Aug 2020 0.630 0.630 0.625 0.630 59,736 -
31 Jul 2020 0.650 0.650 0.620 0.625 180,246 -
30 Jul 2020 0.670 0.675 0.630 0.630 646,920 -
29 Jul 2020 0.655 0.655 0.625 0.625 399,647 -
28 Jul 2020 0.670 0.670 0.650 0.650 343,516 -
27 Jul 2020 0.680 0.695 0.640 0.670 432,150 -
24 Jul 2020 0.635 0.705 0.635 0.700 556,333 -
23 Jul 2020 0.675 0.675 0.635 0.640 245,413 -
22 Jul 2020 0.680 0.680 0.650 0.660 323,026 -
21 Jul 2020 0.755 0.755 0.670 0.700 656,377 -
20 Jul 2020 0.740 0.780 0.690 0.740 704,098 -
17 Jul 2020 0.625 0.705 0.615 0.700 755,937 -
16 Jul 2020 0.610 0.615 0.605 0.605 53,631 -
15 Jul 2020 0.615 0.625 0.605 0.605 234,610 -
14 Jul 2020 0.620 0.625 0.605 0.605 255,703 -
Summary
Current 2 Weeks
(30 Jul 2020 to 12 Aug 2020)
0.670 0.690 0.600 0.625 2,841,453 -
Previous 2 Weeks
(16 Jul 2020 to 29 Jul 2020)
0.610 0.690 0.600 0.625 4,470,128 -
4 Weeks from
(17 Jun 2020 to 15 Jul 2020)
0.640 0.690 0.600 0.605 5,146,058 -
View All Historical Data

More Information Available

More information is available to our subscribers, including:

  • Market Moving News from Dow Jones Newswires
  • Consensus Estimates
  • Dividend/Distribution History
  • Financial Summary with Financial Period Comparison
  • Comprehensive Financial Ratios(ROA, ROE, Price/Revenue, Net Earnings Margin, Current Ratio, Debt to Equity Ratio etc)
  • Events Calendar for Results Announcements, Ex-Dates etc
  • Insider Buying and Selling Report

If you are an existing subscriber, please login. If not, read up on what you are missing out in our Help Centre and join us as a subscriber.

Disclaimer:

While reasonable efforts have been taken to ensure that the calculations performed by the features of this site are reliable, the features are provided on the basis that:-

  1. no liability is accepted for any errors or inaccuracies resulting from your use of these features;
  2. many of the data inputs (including share prices) are obtained from third party sources for which we assume no responsibility.
We use Cookies. By continuing to use this webite, you will be agreeing to our Privacy Policy, Terms and Conditions and Cookie Policy.